Although much attention has been focused on the neurological sequelae of the hereditary ataxias, patients with these conditions also may develop cardiac complications that represent a significant cause of disability and even death. In this article, the authors describe the hereditary ataxias with known cardiac involvement, discuss underlying causes, and review guidelines for screening and treatment. Continued progress will require coordinated clinical trial networks, interdisciplinary care teams, and team science.
KlockgetherTPaulsonH. Milestones in ataxia. Mov Disord. 2011;26(6):1134–1141.
2.
ScholsLAmoiridisGPrzuntekHFrankGEpplenJTEpplenC.Friedreich’s ataxia. Revision of the phenotype according to molecular genetics. Brain. 1997;120(12):2131–2140.
3.
TsouAYPaulsenEKLagedrostSJ. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307(1-2):46–49.
4.
HardingAEHewerRL. The heart disease of Friedreich’s ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. QJM. 1983;52(208):489–502.
5.
ArthamSMLavieCJMilaniRVPatelDAVermaAVenturaHO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis. 2009;52(2):153–167.
6.
RamanSVPhatakKHoyleJC. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur Heart J. 2011;32(5):561–567.
7.
ChannerKSChannerJLCampbellMJReesJR. Cardiomyopathy in the Kearns–Sayre syndrome. Br Heart J. 1988;59(4):486–490.
8.
HubnerGGokelJMPongratzDJohannesAParkJW. Fatal mitochondrial cardiomyopathy in Kearns–Sayre syndrome. Virchows Arch A Pathol Anat Histopathol. 1986;408(6):611–621.
9.
CharlesRHoltSKayJMEpsteinEJReesJR. Myocardial ultrastructure and the development of atrioventricular block in Kearns–Sayre syndrome. Circulation. 1981;63(1):214–219.
10.
YoungTJShahAKLeeMHHayesDL. Kearns–Sayre syndrome: a case report and review of cardiovascular complications. Pacing Clin Electrophysiol. 2005;28(5):454–457.
11.
ClaytonPTWinchesterBGKeirG. Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis. 1992;15(6):857–861.
12.
GrunewaldS. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta. 2009;1792(9):827–834.
13.
RomanoSBajolleFValayannopoulosV. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia). J Med Genet. 2009;46(4):287–288.
14.
GehrmannJSohlbachKLinnebankM. Cardiomyopathy in congenital disorders of glycosylation. Cardiol Young. 2003;13(4):345–351.
15.
PradhanCYashavanthaBSPalPKSathyaprabhaTN. Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability. Acta Neurol Scand. 2008;117(5):337–342.
16.
De JoannaGDe RosaASalvatoreE. Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. J Neurol Sci. 2008;275(1-2):60–63.
OlsonGSHalpeDCKaplanAMSpataroJ. Dandy–Walker malformation and associated cardiac anomalies. Childs Brain. 1981;8(3):173–180.
23.
HartMNMalamudNEllisWG. The Dandy–Walker syndrome: a clinicopathological study based on 28 cases. Neurology. 1972;22(8):771–780.
24.
YaromRFriedK. Hypertrophy of heart with outflow tract obstruction and myocardial necrosis in an infant with multiple congenital malformations. Br Heart J. 1971;33(3):420–422.
25.
SautreauxJLGiroudMDauvergneMNivelonJLThierryA. Dandy–Walker malformation associated with occipital meningocele and cardiac anomalies: a rare complex embryologic defect. J Child Neurol. 1986;1(1):64–66.
26.
DaveyKMParboosinghJSMcLeodDR. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition. J Med Genet. 2006;43(5):385–393.
27.
SparkesRPattonDBernierF. Cardiac features of a novel autosomal recessive dilated cardiomyopathic syndrome due to defective importation of mitochondrial protein. Cardiol Young. 2007;17(2):215–217.
28.
SalmanMSClarkeJTMidroniGWaxmanMB. Peripheral and autonomic nervous system involvement in chronic GM2-gangliosidosis. J Inherit Metab Dis. 2001;24(1):65–71.
29.
HuangMLBeckerEMWhitnallMSuryo RahmantoYPonkaPRichardsonDR. Elucidation of the mechanism of mitochondrial iron loading in Friedreich’s ataxia by analysis of a mouse mutant. Proc Natl Acad Sci USA. 2009;106(38):16381–16386.
30.
RotigAde LonlayPChretienD. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215–217.
31.
LodiRCooperJMBradleyJL. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA. 1999;96(20):11492–11495.
32.
PandolfoM. Iron and Friedreich ataxia. J Neural Transm Suppl. 2006(70):143–146.
33.
SchulzJBDehmerTScholsL. Oxidative stress in patients with Friedreich ataxia. Neurology. 2000;55(11):1719–1721.
34.
PayneRM. The heart in Friedreich’s ataxia: basic findings and clinical implications. Prog Pediatr Cardiol. 2011;31(2):103–109.
35.
OlivottoIGirolamiFSciagraR. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011;58(8):839–848.
PitceathlyRDFassoneETaanmanJW. Kearns–Sayre syndrome caused by defective R1/p53R2 assembly. J Med Genet. 2011;48(9):610–617.
38.
MoraesCTDiMauroSZevianiM. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns–Sayre syndrome. N Engl J Med. 1989;320(20):1293–1299.
39.
AnanRNakagawaMMiyataM. Cardiac involvement in mitochondrial diseases: a study on 17 patients with documented mitochondrial DNA defects. Circulation. 1995;91(4):955–961.
40.
JaekenJ. Congenital disorders of glycosylation. Ann N Y Acad Sci. 2010;1214:190–198.
41.
MaschhoffKLBaldwinHS. Molecular determinants of neural crest migration. Am J Med Genet. 2000;97(4):280–288.
42.
BullPCThomasGRRommensJMForbesJRCoxDW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5(4):327–337.
43.
TanziREPetrukhinKChernovI. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5(4):344–350.
44.
FerenciP. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis. 2004;19(3-4):229–239.
45.
HardingAEHewerRL. The heart disease of Friedreich’s ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Quarterly J Med. 1983;52(208):489–502.
46.
AlbanoLMNishiokaSAMoysesRL. Friedreich’s ataxia: cardiac evaluation of 25 patients with clinical diagnosis and literature review. Arq Bras Cardiol. 2002;78(5):444–451.
HuntSAAbrahamWTChinMH. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):e1–e90.
49.
MancusoMOrsucciDChoubASicilianoG. Current and emerging treatment options in the management of Friedreich ataxia. Neuropsychiatr Dis Treat. 2010;6:491–499.
50.
MyersLFarmerJMWilsonRB. Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008;267(1-2):174–176.
51.
KempKMallamEHaresKWitherickJScoldingNWilkinsA. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts. PLoS One. 2011;6(10):e26098.
